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SUMMARY
This Manuscript is based on a series of lectures to the students and staff of the Departament
do B1ologia Fonamental, Universitat Autonoma de Barcelona and forms a review of the progress
towards the development of techniques and methods to:
a. Culture cells of the preimplantation mammalian embryo.
h. Use totipotent embryonic stem cells to create animal models for the study of inherited
genetic defects and development.
c. Biopsy and diagnosis of genetic diseases using the preimplantation embryo.
Derivation and use of embryonic
stem ( ES) cell lines from the inner cell
mass of the mouse blastocyst
Mouse embryonic stem cell lines provide
an in vitro system with which studies may be
undertaken on differentiation and development,
either by inducing the totipotent cells to
differentiate into a variety of different cell
types following exposure to retinoic acid, or
when injected into murine blastocysts, their
contribution to somatic tissues and the germ
line. Robertson in 1987 provides details on a
practical approach to isolate and culture
pluripotential mouse cell lines. Most ES cell
lines are poorly characterised in terms of
karyotype and stability of totipotent phenotype.
One of the major problems is the maintenance
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of a normal diploid karyotype as population
doubling levels (PDLs) progress. This may
explain why only a proportion of ES lines are
able to contribute to somatic and germ cells
when injected into blastocysts. Recent studies
(5) have shown that the E 14 cell line (13, 15) is
now unable to form chimeras following its
injection into blastocysts and concomitant with
this has been an increase in the frequency of
aneuploidy. The conditions for the derivation
of ES cell lines in our own laboratory have
recently been described (5) together with full
phenotypic characterization in order to optimize
their use for genetic manipulation. These
studies have defined the phenotype and
genotype of mouse ES cell lines MESC.
Parameters include I ). an accurate estimate of
the replication at each population doubling
level (PDL) rather than the vague term of
"passage". The term passage reflects the number
of times a culture of cells (of unknown number
and viability) is trypsinised and subcultured.
2). karyotype and sex, 3). cell size which is
measured prior to the time of injection and
indicates stage of cell cycle, 4). A biochemical
marker e. g. Glucose-6-phosphate-isomerase
(GPI), which can verify the genotype of the
injected cells. The number ofcells injected and
their contribution to somatic tissues and the
germ line was also noted. These studies showed
that the totipotent ES cell phenotype and
karyotype are unstable in vitro and that there is
an in vitro "window of opportunity" during the
culture of ES cells which allows a higher rate
of successful integration of injected cells into
the germ line (5). The conclusion from these
studies was that a full characterisation of the
cells is required at selection, transfection and
prior to injection into the blastocysts, otherwise
the use of ES cell lines will remain inefficient
and restricted.
Mouse ES cell lines (MESC) were derived
from blastocysts of C57BL/6J, CBA/Ca and
129/J Olac inbred; C57BL/6JxCBA/Ca F,
hybrids; and MFI random-bred stocks. Eight
of these lines have a normal karyotype, the
remainder are aneuploid. The infrequent
retention of the normal karyotype in ES cell
lines has been previously observed. One of the
aneuploid ES cell lines has been shown to
contain a single Robertsonian translocation
chromosome with a symmetrical, homologous,
arm composition Rb(I I.1 I) (7). Although
unsuitable for the production ofanimal models,
this spontaneous occurrence and stable retention
of the homologous Rh(11.11), as the only
metacentric chromosome in an otherwise
acrocentric karyotype, provides a potentially
usefuld tool for cytogenetic studies.
Cytogenetic diagnoses ofembryonic cells
The most common type of chromosomal
abnormality is the presence of an extra
chromosome, trisomies. The majority of
autosomal trisomies are lethal, and result in
failure at implantation or early spontaneous
abortion. The three commonest surviving
autosomal trisomies in man are those for
relatively small chromosomes; trisomy 21
(Down syndrome), 13 (Patau syndrome), and
18 (Edwards syndrome). Even in these cases,
most affected embryos abort e.g. only 20%k% of
Down syndrome embryos attain viability. The
most common cause of chromosomal failure is
nondisjunction, that is, a failure of the relevant
chromosome pair to separate at meiosis, usually
during the first meiotic division. In 80% of
cases of autosomal trisomy, the causative non-
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disjunction takes place in the mother and this
becomes increasingly common with advancing
age. The incidence of these trisomies rises with
maternal age. Many of the patients within an
IVF programmes are within a vulnerable age
area, and thus the incidence of chromosomal
abnormalities following fertilisation is
increased.
Cytogenetic analysis of biopsied 4, 8 and
morula stage mouse preimplanation embryos
has demonstrated that air-dried preparations
can be G - banded and karyotyped by
modifications of routine banding methods.
Biopsied material placed in colchicine yielded
the greatest mitotic index, however,
chromosomal morphology was unsuitable for
G-hand analysis . 71.4% offixed 8 -cell biopsies
were karyotyped (26) although this success
rate is not acceptable for the direct application
of this technique to human preimplantation
diagnosis, it represents a usefuld system to
study chromosomal error at the research level
and may, with further modifications be
improved so that initial studies can be
undertaken on "spare" human early cleavage
embryos. Cytogenetic analyses may then be
performed on biopsies from preimplantation
embryos in instances ofa parental chromosomal
rearrangement , for sex determination in cases
where DNA studies are uninformative or in
combination with in-situ hybridisation with
specific probes for chromosome identification
(I I ). Cytogenetic studies have been undertaken
on single blastomeres of a two-cell mouse
embryo and on 2 blastomeres from four-cell
embryos with 65 -70% success . The methods
used to achieve this success could be best
utilised where additional chromosomes are to
he detected ( Vidal and Gimenez , personal
communication).
If such methods are to be used for human
embryos it would be dependant on the
production of biopsied material which yields
successful karyotypes with a high degree of
efficiency. This could be achieved by
developing methods which are sensitive enough
to detect chromosomal abnormalities in indivi-
dual orsmall numbers of cells using mouse and
human cell lines with known chromosomal
defects (Trisomy 21, Robertsonian
translocation) for in situ hybridisation,
cytogenetic and other analyses. A variety of
cells and tissues could be used for example: a)
A mouse embryonic cell line has been deri ved
which has a known Robertsonian
translocation; this cell line will be a useful tool
in studying the behaviour and detection of cells
with a translocation in vitro.; h) Human cell
lines which have various trisomies; () "Spare"
human embryos from IVF facilities which
have been shown to have major abnormalities
(triploid); and d) Material derived from
amniocentesis and chorionic villus sampling
(CVS) from patients undergoing prenatal
diagnosis.
There is the possibility of using techniques
for the DNA amplification of particular cell
chromosomes in a similar manner to studies
recently undertaken on the Y chromosome
repeat in a single blastomere which detected
the sex of the mouse embryo (11). Biopsied
human embryos have established succesful
pregnancies and babies have been born (13).
This technique allows those embryos with the
possibility of sex linked defects e.g. Lesch-
Nyhan to be identified and not returned to the
patient. Cytogenetic analysis of sperm from a
human male heterozygous for a 13:14
Robertsonian translocation has used sperm
and the in vitro penetration of hamster eggs (16).
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Creating mouse models for inherited
genetic diseases
Animals with modified genomes can be
created from genetically manipulated
embryonic stem (ES) cells or by the direct
injection ofDNA into the pronuclei of fertilized
eggs. The ES cell approach allows the creation
of transgenic animals with predetermined
genetic modifications. The ES cells have the
distinct advantatge in that they can be selected
for specific genetic modification before
producing transgenic animals. The genetic
modifications may be achieved by manipulation
ofendogenous genes by targeting and disruption
by homologous recombination, or mutagenic
agents
Animal models of human disease may be
used for molecular, biological and
physiological characterisation of the defect
where the developmental consequences can be
studied. Also, an evaluation of therapeutic
procedures and the possibility of gene therapy
could be undertaken to correct or modify the
defect in mouse models.
Lesch-Nyhan mouse model
The structural gene for hypoxanthine
guanine phosphoribosyl transferase (HPRT) is
X-linked in mice and humans and HPRT
variants occur at a relatively high frequency in
cultured cells of male origin. The disease is
characterized by mental retardation and self
mutilation and death before puberty in human
males. Chimeric mice deficient for the HPRT
enzyme which is encoded by a gene on the X-
chromosome were derived using the stem cell
line strategy (15). The mutant has a large gene
deletion involving the first two exons of the
coding sequence, which prevents transcription
at the mutant locus. The chimeras have been
used to: a. establish a breeding colony on MF I
and 1298 backgrounds and b. undertake studies
on their breeding performance and examine
the fate of normal and HPRT deficient cell
lineages (1).
Tay-Sachs mouse model
In humans, the onset of the infantile form of
Tay Sachs disease occurs within the first year
of life leading to death in early childhood after
progressive motor and mental deterioration. In
adults the disease onset usually occurs in the
second or third decade with motor neuron,
pyramidal tract, and cerebellar deterioration.
The properties of A and B forms of the
enzyme provided the biochemical basis for the
first simple screening tests for Tay-Sachs
carriers and prenatal diagnosis by amniocentesis
and chorionic villus biopsy. The main questions
of interest about Tay-Sachs disease concerns
the mechanism(s) of dysfunction which are
presently unknown and maybe attributable to:
various neurological symptoms or simply to
storage ofGM2 gangliosides within lysosomes
and the concomitant mechanical effects of this
engorgement. With a mouse models it should
be possible to analyze the relationship between
GM2 accumulation in various parts ofthe brain
with the observed dysfunction.
To obtain models for the infantile and adult
forms ofTay Sachs disease we are targeting the
Hexosaminidase A gene by homologous
recombination and injection of the transfected
and selected ES cell into mouse blastocysts.
Culture of preimplantation human
embryos
The majority of early cleavage human
embryos block and/or degenerate when cultured
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from the one-cell stage. Due to the lack of
human embryos available for basic research
very little is known of the factors affecting the
viability of the cultured human embryo;
whereas, a variety of conditions are known
which can influence or overcome the in vitro
2-cell block in the mouse (2 I ). The
marine in-viU-o 2-cell block coincides with the
time when the genome is first
expressed. Humangeneexpressiontirstoccurs
between the tour -and eight-cell stages of
preinrplantation development (4), which is
when an in-vitro block also occurs.
Only 17%ofculturedhumanembryosreach
the blastocyst stage in Earle's medium. We
have shown that a dramatic improvement in
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the culture of the early human pre-implantation
embryo can be achieved using commercially
available Ham's F-12 medium (Figure 1). This
data shows that there is a variability in the
in-vitrodevelopmentoftheembryoseven when
similar staged embryos were used at the
initiation of the culture period in Ham's F-12
(22, 23). The greatest variability observed is at
the 8-12 stage which is where the greatest
percentage of human embryos "blok"in-vitro.
The viability of the cultured blastocysts was
assessed by allowing them to outgrow on
different substrates in vitro. Table 1 shows the
attachment and outgrowth of cultured zona-
intact and zona-free or thinned (acid tyrode's
treated) human blastocysts on different
substrates.
Human Embryo Development in Ham's F-12
X:^C XX
♦ X X
f.lflfl
X
Individual Embryos
^^
X X X X X
X X X
O-{!^ 10-141 41 O ^^
^ 2-cell
q 4-cell
♦ 8-12 cell
Q E.morula
^ L.morula
X Blastocyst
Fic^ ^^ut^_ I .These data denumstrate that a variability in rate of cleavageand development occurs in Ham's F-12 media
despite using similar staged embryos at the initiation of the culture period. The gratest variability occurs at the B-
tu I ^-cell stage of development. Thirty-six individual embryos obtained from different donors were used for these
experiments. (Reproduced from Muggleton-Harris, et al. Hum. Reprod. 5, 2, 217-220, 1990.)
168 A. L. MUGGLE77)N-HAKKIS
TABLE:
Attachment and outgrowth of zonae intact and AT treated Grade 1 and 2 human blastcxysts
on different substrates
Cultured on feeder cells Attached outgrowth Attached outgrowth
(A), fibronectin (B) or degenerated disaggregated
gelatin (C) substrates in (t)'' (t )''
F-12/BRL media
Zonae intact embryos
I C
2 C
3 C
4 C
5 C
6 C
7 C
8 C
+(48)
+(48)
The table showy the attachment and outgrowth of A"I'-Beated and tuna-intact blastocysts on feeder cell, fibrunectin and gelatin
substrates. The majority of the blastocysts either began to attach and tiirm an outgrowth, then degenerated belbre disaggregation
could occur, or attached and formed outgrowths which could be disaggregated. The time of degeneration or disaggregation is
also shown. Some blastocysts from both groups did not form outgrowths and are represented by (-) in both columns.
'Cultured in F-12 media plus 170 nanolitres/ 1 of progesterona on Fibronectin. ^[, time of disaggregation ofoutgrowth ordegeneration
of outgrowth in hours. Embryos from both AT-treated and zonae intac degenerated and did not form outgrowths.
(Reproduced from Muggleton-Harris and Findlay, Hum. Reprod. 6 I, 85-92, 1991.)
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A BLASTOMERE BIOPSY FROM EARLY
CLEAVAGE EMBRYO
Pipette delivering (AT)
Acid tyrodes to drill a
hole in zone pellucida
Glass Holding Pipette
Zonae pellucida
Glass Holding P?pette
One blastomereremoved
by suction through hole
in AT drilled zonae
B BLASTOCYST-TROPHECTODERNI
CELL BIOPSY
Inner cell mass cells
Silicote covered
glass microneedle
Glass microneedle
Trophectoderm cells
AT thinned zonae pellucida
A
3 trophectoderm cells being drawn through AT thinned zonae
(sometimes the blastocyst collapses during this operation but
the -mbryo will recavitate within 40 mins).
FIGURE. 2. (Reproduced from Muggleton- Harris and Findlay, Hum. Reprod. 6: 85-92, 1991.)
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Biopsy of the pre-implantation
mammalian embryo
There are two approaches to obtaining
embryonic cells forpreimplantation diagnosis,
either during early cleavage or at the blastocyst
stage (Figure 2). Each has advantages and
problems and we have examined ways to
improve the viability ofbiopsied embryos using
both approaches.
Cleavage stage biopsi
There are two major advantages ofcleavage
stage biopsy. The totipotency of hlastomeres
up to the 8-cell stage is well established and,
depending upon stage, one blastomere can he
removed without impairment of subsequent
development. Also, the transfer of early
cleavage stage biopsied human embryos to the
uterus has resulted in established pregnancies
and live offspring (13). The major limitation is
the small amount of biopsy material which
allows only a single analysis to be undertaken.
It is always desirable to be able to perform
replicate diagnoses, (in case of ambivalent
results). Another drawback is the removal of
blastomers that would have contributed to the
fetus which may have ethical ramifications.
Blastocyst stage biopsy
The advantages of blastocytst stage biopsy
are: trophectoderm cells can be removed easi ly
with simple glass microneedles rather than
having three different sized glass micropipettes
attached to syringes (this is an important
consideration if these techniques are to be used
in IVF facilities). Also the trophectoderm cells
do not contribute to the embryo proper and
sufficient number of cells can be initially re-
moved allowing for more than one diagnoses.
Many genetic diseases show extensive
heterogeneity, and additional testing can be
undertaken to defect for other genetic diseases.
This strategy may be applied to the screening
of human embryos obtained by IVF or uterine
lavage (6, 3) to identify those embryos
appropriate for transfer. We have shown that
the trophectoderm biopsy procedure readily
allows sufficient cells to be removed which
could be used for duplicate analyses in both
mouse and human embryos (22,23,24). Recent
results has shown that 5 pregnancies were
established from 21 transfers of early cleavage
stage embryos whereas 9 pregnancies were
established when 27 blastocysts were
transferred.
In vitro studies on biopsied eels
The growth and proliferation of
extraembryonic cells from the pre I in plantation
mouse blastocyst have been examined in vitro.
Micromanipulation procedures were used to
isolate various subsets of trophectoderm cells.
A mitotically active population of polar
trophectoderm cells has been identified which
proliferate rapidly in suitable in-vitro
conditions ; these cells were only observed
when the majority of the mural trophectoderm
was removed from the 1CM/polar
trophectoderm cell populations (22, 23).
Unfortunately we have not been successful in
establishing cultures from extraembryonic
mouse trophectoderm cells or as shown in
Table Il, human abembryonic trophectoderm
cells.
Biopsied mouse and human cells have been
cultured using a variety ofsubstrates and culture
conditions to stimulate replication of
blastomeres (22, 23, 24). Using " spare" human
embryos which have been donated for research
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TABLFi I1
1+'ate of zonae thinned blastocysts following biopsy of three to five trophectoderm cell
Cultured on feeders (A), Attached Attached/ Fatc of biopsied cells 24h
tibronectin (B), gelatin outgrowth outgrowth post-biopsy
(C) in F-I?/BRL degenerated disaggregated
I^hc lahle sho^cs the fate uf^iopsied, zona-thinned hlastocysts and non-biopsied, zona-thinned controls on feeder cell, fibronectin
and grlutin wbstrates. The majority of the blastocysts either began w attach and form un outgrowth and then degenerated before
disaggrcg;uion could occur, or attached and formed outgrowths which could he disaggregated. The fate of the biopsied
trophectoderm cells is also shown.
fRepmduced from Muggleton-Harris and Findlay, Hum. Reprod. 6: I, 85A2, 1991.)
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from an IVF facility, we have shown (Table
III) that a single human blastomere can replicate
within 18-24 hours in vitro (23, 24). This
would provide the means of ensuring that
duplicate cells were available when a single
human blastomere is removed for diagnosis.
Since it has been shown that a human blastomere
can be removed at the 4- 8 cell stage without
adverse affects ( 13, 14), this is now a realistic
approach to diagnosis.
TABLE Ill
Representative sample of replicating
individual blastomeres
from grade 3 embryos cultured
on a gelatin substrate in F-12/I3RL media
Embryo No. of blastomeres Finite number
in embryo of replications
of each
blastomere (U
1 4 2(48)
2 4 1(24)
3 6 4(18)
4 8 1(20)
5 4 1(18)
6 4 3(72)
7 4 3(18)
8 6 4(24)
9 8 4(18)
10 4 2(48)
The table shows a representative sample of replicating
individual blastomeres on a gelatin substrate in F-I2/BRL.
The number of regular sized blastomeres within the embryo is
shown and the number of replications observed from each
individual biopsied blastomere. The tine for the first replication
to he observed is also shown.
(t), time of first replication in hours.
(Reproduced from Muggleton-Harris and Findlay, Hun.
Reprod. 6: 1. 85-92, 1991.)
Analysis of inherited genetic defects
in the pre-implantation embryo
Detection ofan enzyme deficiency in the
HPRT deficient mouse
Hypoxanthine phosphoribosyl transferase
(HPRT) deficient male embryos derived from
heterozygous (carrier) female mice have been
diagnosed by a biochemical microassay of the
X-cromosomecoded HPRT activity in a single
blastomere and in 5-10 trophectoderm cells
sampled from the blastocyst (17, 18, 19, 20).
The biopsy of trophectoderm cells at the
blastocyst stage distinguished carrier female
embryos from affected males, and normal males
and females as having intermediate HPRT
activity. Confirmation of the diagnosis was
made on fetuses developing from the biopsied
embryos after transfer into pseudopregnant
recipient mice. All HPRT negative and carrier
female embryos were correctly diagnosed from
the enzyme analysis of the biopsied cells.
Detection of a gene deletion in the
shiverer mouse mutant
The mouse mutant shiverer (shi/shi) is
characterized by tremors, hypomyelination of
the central nervous system and a shortened
life-span was selected for use. The gene
encoding myelin basic protein (MBP) a major
component of the central nervous system
myelin, has been largely deleted in shiverer
mice. The normal MBP gene has seven exons
which have been sequenced while the MBP
gene has only exon I and 2, the 5 prime
breakpoint of the MBP gene has been
sequenced. The aim was to identify the mutant
and normal MBP genes in biopsied
trophectoderm cells obtained from the
preimplantation blastocyst using the biopsy
procedures developed previously (Figure 3).
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BIOPSY PROCEDURE OF PRE-IMPLANTATION EMBRYO
Micromanipulation dish STEP 1 Er.!nrgement of 1 drop
Inner cam mass
(Embryonic)
3L-
OR
4 day
preim-
plantation
embryo
paid dish
STEP 3
3 extraembryonic cells
removed and placed
into a mlcrocap -
wild
type
allele
+!+
STEP 8
Manipulated embro placed
in a drop medium to be
cultured in incubator
for 7 hours
shi /shi allele
PCR products run an an agarose gel &
stained with ethidlum bromide
STEP 5
STEP 4
Embryo 1 Embryo 2
Manipulated Non-manipulated
3 calls in Est. water / 1 aliquot . kept cold on dry ice
STEP 6
aliquot split
into 2 aliquots
STEP 7 -ad*-
Potymerase
chain
reaction ( PCR) (PCR ) Analysis Store 2nd
(approx . 5-7hours ) on I aliquot aliquot in freezer
to confirm diagnosis
la Rt: 3. A flow diagram demonstrating the PCR assay of trophectoderm biopsy samples.
(Reproduced from Readhead and Muggleton-Harris, Hum. Reprod. 6: 93-100. 1991.)
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The results demonstrated that preimplantation
diagnosis using polymerase chain reaction
(PCR) could be completed in less than seven
hours. The rapid preimplantation detection of
mutant (shiverer) and normal alleles of the
mouse myelin basic protein gene allowed
selection of the non-affected blastocysts for
transfer into recipient mice, the implantation of
the biopsed embryos to establish pregnancies
and subsequent birth of live young (8, 9, 25). In
these studies, the identity ofeither amplification
product was proved conclusively by direct
sequence analysis of amplified products. The
possibility forgerm line therapy ofthis disorder
has already been demonstrated by producing
transgenic mice for the wild type MBP gene (25).
Detection ofsingle-base-pair mutations
in a Hb5 transgenic mouse
In humans, the most common form of sickle
cell anaemia results from a single base pair
mutation in codon 6 ofthe human (3-globin gene
causing a single amino-acid substitution.
Sickling of cells in small vessels causes painful
crisis and other life threatening complications.
We are developing a clinical test involving
PCR amplification of the relevant part of the
Hb' gene to detect in the human embryo. To
devise appropiate analysis procedures' we
obtained a transgenic mouse carrying the human
Hb' gene and manifesting the sickle cell trait
(10). Oligonucleotides have been constructed
to amplify a fragment of DNA from the Hb'
gene at a high level of sensitivity. Our eventual
aim is to be able to distinguish between normal,
carrier and defective in transgenic mice and to
apply these techniques to human embryos from
"at risk" patients.
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